Anxiety Is Not Always
a Mindset Problem —
COMT, Cortisol, and the
Biochemistry of a Wired
Nervous System

The standard advice for anxiety is delivered with such consistency that it has become almost reflexive: breathe, practise mindfulness, challenge your thoughts, perhaps take an SSRI while you build those skills. The advice is not wrong. Breathing regulation genuinely modulates the autonomic nervous system. Mindfulness has a meaningful evidence base. Cognitive approaches help people develop more useful relationships with anxious thinking. For many people, this is enough.

For a significant and identifiable proportion of people with anxiety, it is not enough — because the anxiety is not primarily a thinking problem. It is a biochemical one. The nervous system is not reacting disproportionately to perceived threat because of faulty cognition. It is reacting because the neurochemical environment makes calming down structurally difficult: catecholamines accumulate faster than they clear, cortisol rhythm is dysregulated, oestrogen metabolism is impaired, and the methylation cycle that governs all of these processes is running at reduced capacity. You can practise mindfulness from morning to night and you will not meaningfully alter the COMT V158M variant that is slowing your catecholamine clearance.

This post maps the biochemical architecture of anxiety — the mechanisms that create a wired, reactive, hard-to-calm nervous system — and explains what functional testing reveals about which of these mechanisms is operative in any given individual.

COMT — the enzyme that clears
dopamine, adrenaline, and oestrogen.

Catecholamines — dopamine, noradrenaline, and adrenaline — are the neurochemicals of alertness, focus, motivation, and acute stress response. They are produced rapidly under demand and are supposed to be cleared equally rapidly when the demand passes. The enzyme primarily responsible for their clearance in the prefrontal cortex and other brain regions is COMT — catechol-O-methyltransferase.

COMT uses SAM (S-adenosylmethionine, the universal methyl donor) to methylate and thereby deactivate catecholamines. Its activity is directly dependent on methylation cycle capacity. When the methylation cycle runs well and SAM is abundant, COMT clears catecholamines efficiently. When SAM is depleted — by MTHFR variants, B vitamin insufficiency, chronic stress, or synthetic folic acid impeding folate conversion — COMT slows and catecholamines accumulate.

There is also a common genetic variant — COMT V158M — that directly affects enzyme activity independent of SAM availability:

The met/met (slow COMT) variant is sometimes described as the "worrier" genotype — not because carriers are constitutionally anxious personalities, but because their neurochemical environment makes it harder to down-regulate the stress response once activated. The prefrontal cortex stays bathed in dopamine and noradrenaline longer after the stressor has passed. The threat detection circuitry remains sensitised. Calming requires more effort and takes longer — not because of a character deficiency but because the enzymatic clearance mechanism is slower by design.

HPA dysregulation — when the
stress system loses its rhythm.

The HPA axis — hypothalamic-pituitary-adrenal — is the body's central stress response system. Under normal conditions it operates in a precise rhythm: cortisol peaks in the hour after waking (the cortisol awakening response, or CAR), tapers through the afternoon, and reaches its nadir in the evening to allow sleep onset and overnight repair. This rhythm is not cosmetic. It governs immune function, blood sugar regulation, anti-inflammatory capacity, and the sensitivity of the stress response itself.

Anxiety disorders are consistently associated with HPA dysregulation — but not always in the direction most people assume. There are two distinct patterns:

The clinical significance of knowing which pattern is operating is that the intervention differs completely. High-cortisol anxiety needs a different approach from flat-cortisol anxiety. Adaptogens, for example, are frequently recommended for anxiety without any knowledge of which cortisol pattern is present — and an adaptogen that modulates a flat cortisol curve upward can worsen a high-cortisol pattern significantly. This is a direct clinical illustration of why testing before supplementing matters.

MTHFR, folate, and why
anxiety follows the same pathway as depression.

The previous post in this series traced the connection from MTHFR variants to depression via tryptophan diversion and serotonin deficit. Anxiety follows some of the same upstream pathway but diverges in important ways — and often coexists with the depressive picture in the same person precisely because both are downstream of the same methylation dysfunction.

The specific connections between methylation and anxiety:

• SAM depletion reduces COMT activity. Reduced SAM → slower COMT → catecholamine accumulation → sustained sympathetic activation → anxiety. This is the direct enzymatic link between methylation capacity and anxiety biochemistry. MTHFR C677T reduces folate conversion → reduces 5-MTHF → reduces remethylation of homocysteine → reduces methionine → reduces SAM production. The chain is long but the logic is unbroken.
• BH4 depletion impairs GABA synthesis. Tetrahydrobiopterin (BH4) is a cofactor for several neurotransmitter synthesis enzymes. Its production depends on adequate folate and methylation capacity. BH4 is required for nitric oxide synthase and for the synthesis of serotonin and dopamine — but critically for anxiety, it is also a cofactor in the pathway that produces GABA (gamma-aminobutyric acid), the primary inhibitory neurotransmitter. Reduced BH4 from methylation dysfunction can impair GABAergic tone — the very mechanism that benzodiazepines target pharmacologically. Impaired natural GABA capacity produces a nervous system that is constitutionally harder to calm.
• Elevated homocysteine directly activates NMDA receptors. Homocysteine — the methylation cycle metabolite that accumulates when the cycle stalls — is a partial agonist at NMDA glutamate receptors. Chronically elevated homocysteine produces a degree of excitotoxic neurological activation. This is one mechanism through which elevated homocysteine independently contributes to anxiety and cognitive instability, separate from its cardiovascular effects.
• Synthetic folic acid and MTHFR — the compounding problem. For individuals with MTHFR C677T homozygous or compound heterozygous variants, synthetic folic acid from fortified food competes with natural folate at receptor sites and produces unmetabolised folic acid (UMFA) in the bloodstream. UMFA has been associated with reduced folate bioavailability at the cellular level — potentially worsening the methylation deficit that is driving COMT slowing, homocysteine elevation, BH4 impairment, and GABA insufficiency simultaneously. The folic acid fortification policy beginning in 2026 will increase UMFA load specifically in the population most at genetic risk of these downstream effects.

Why gut health appears
in almost every anxiety clinical picture.

The gut-brain axis is not a new concept, but its specific relevance to anxiety goes beyond the general observation that the gut produces neurotransmitters. Several specific mechanisms link gut dysbiosis to anxiety in ways that are clinically actionable:

The vagus nerve and the threat signal

The vagus nerve carries signals bidirectionally between the gut and the brain stem. Approximately 80% of its fibres are afferent — carrying information upward from the gut to the brain, not downward. The quality of the microbial environment in the gut directly influences the signals that travel via the vagus nerve to the brain's threat-detection circuitry. Dysbiotic gut bacteria produce LPS (lipopolysaccharide) and other metabolites that generate a persistent threat signal in the brain via this pathway — maintaining a low-level neurological alarm state that feeds anxiety without any external stressor being present.

Butyrate and GABAergic tone

Short-chain fatty acids — particularly butyrate — produced by commensal gut bacteria have direct effects on central nervous system function. Butyrate crosses the blood-brain barrier and influences GABAergic neurotransmission and microglial function. Depleted butyrate producers (Faecalibacterium prausnitzii, Roseburia) — the exact species most sensitive to glyphosate's antibiotic mechanism and most depleted in Western gut microbiomes — are associated with reduced central GABAergic tone. This creates a mechanistic connection between diet, gut microbiome composition, and the brain's inhibitory nervous system capacity that operates entirely independently of conscious psychological processes.

Histamine and the COMT-oestrogen-histamine triangle

Certain gut bacteria — particularly Morganella morganii and some Lactobacillus strains — produce histamine from dietary histidine. Histamine in excess activates the sympathetic nervous system, impairs sleep, produces racing heart, and creates an anxiety-like physiological state. HNMT (histamine N-methyltransferase) — the enzyme that clears histamine — uses SAM as its methyl donor. Slow COMT + impaired methylation + histamine-producing dysbiosis creates a compounding triple burden: catecholamines accumulate, oestrogen accumulates, and histamine accumulates, all through the same depleted methylation resource. The GI-MAP identifies histamine-producing bacterial species directly.

The testing picture for anxiety —
mapping the biochemical architecture.

The value of functional testing in anxiety is not to replace psychological or psychiatric assessment. It is to identify which biochemical mechanisms are operative — because the intervention for slow-COMT catecholamine accumulation is different from the intervention for flat-cortisol HPA dysfunction, which is different again from the intervention for histamine-producing gut dysbiosis. Treating anxiety as a single entity with a single intervention is the problem. Testing makes the specific picture visible.

What you can address now —
before, alongside, or instead of testing.

Support the methylation cofactors that COMT depends on

SAM availability is the primary modifiable variable in COMT function. Methylcobalamin B12, riboflavin (B2 — often the most underdosed cofactor), zinc, and magnesium all support methylation cycle capacity and therefore COMT enzyme activity. These are low-risk at moderate doses and relevant to anyone with anxiety regardless of whether MTHFR genotyping has been done. Shifting dietary folate toward food forms (leafy greens, liver, legumes) rather than relying on fortified grain products reduces the UMFA burden on the conversion pathway.

Address the cortisol rhythm at the lifestyle level first

Morning light exposure within 30 minutes of waking — even cloudy Scottish daylight — is the most powerful free intervention for cortisol awakening response. It sets the cortisol rhythm and its downstream effects on HPA reactivity for the whole day. Blood sugar stability through the day (adequate protein at each meal, avoiding refined carbohydrate spikes) prevents the cortisol surges that feeding an anxious HPA axis erratically. These are not supplements. They are the substrate that makes every other intervention more effective.

Build the gut before targeting the brain

Dietary diversity — 30+ different plant species per week — is the most accessible intervention for butyrate-producer diversity. Fermented foods (kefir, sauerkraut, kimchi, live yoghurt) provide direct Lactobacillus input. Reducing ultra-processed food, seed oils, and antibiotic-adjacent compounds (including glyphosate-containing conventional grain products where possible) reduces the selective pressure on the beneficial species most associated with GABAergic tone and vagal signalling quality.

Be cautious with stimulants and adaptogens without a cortisol picture

Caffeine accelerates catecholamine release and slows COMT-mediated clearance in slow-COMT individuals. High-dose B vitamins without methylation context can over-methylate in COMT-slow individuals. Adaptogens prescribed without knowing the cortisol pattern can drive the HPA in the wrong direction. The single most dangerous thing in the functional health supplement market is the recommendation of potent neurochemical modulators without any measurement of what they are modulating.